InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (10 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
10
T+90 hit rate
0%
T+90 mean return
-11.9%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Wassil Jim, Chief Operating Officer. Director active across 2 companies, notably Vaxcyte, Inc.. Aggregated, 45 filings have been logged. Breakdown: 0 buy · 10 sells. Total volume traded: €984k. History available since 24 February 2022. The latest transaction was filed on 1 July 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations45 total
516 shares@ US$5.350.0000% mcap0.1% of flowCommon StockSEC:0001813798-26-000013:0
1,788 shares@ US$56.030.0012% mcap5.4% of flowCommon StockSEC:0001813798-26-000013:1
456 shares@ US$57.4730.0003% mcap1.4% of flowCommon StockSEC:0001813798-26-000013:2
6 shares@ US$57.820.0000% mcap0.0% of flowCommon StockSEC:0001813798-26-000013:3
2,250 shares@ US$56.8310.0018% mcap44.4% of flowCommon StockSEC:0001813798-26-000010:0
2,250 shares@ US$56.8310.0018% mcap44.4% of flowCommon StockSEC:0001813798-26-000010
74,000 shares0Common StockSEC:0001649094-25-000038:0
21,726 shares0Common StockSEC:0001649094-25-000039:0
8,000 shares@ US$2.421.3% of flowCommon StockSEC:0001649094-25-000010:0
8,000 shares@ US$2.421.2% of flowCommon StockSEC:0001649094-25-000002:0
8,000 shares@ US$2.421.2% of flowCommon StockSEC:0001649094-24-000114:0
8,000 shares@ US$2.421.2% of flowCommon StockSEC:0001649094-24-000090:0
1,585 shares@ US$5.350.5% of flowCommon StockSEC:0001649094-24-000086:0
8,000 shares@ US$2.421.2% of flowCommon StockSEC:0001649094-24-000076:0
10,000 shares@ US$2.421.4% of flowCommon StockSEC:0001649094-24-000068:0
10,000 shares@ US$2.421.5% of flowCommon StockSEC:0001649094-24-000066:0
2,977 shares@ US$78.837514.4% of flowCommon StockSEC:0001649094-24-000044:0
1,226 shares@ US$75.75485.7% of flowCommon StockSEC:0001649094-24-000027:0
1,634 shares@ US$71.3847.1% of flowCommon StockSEC:0001415889-24-015587:0
1,753 shares@ US$61.2276.6% of flowCommon StockSEC:0001415889-24-012166:0
3,551 shares@ US$5.351.2% of flowCommon StockSEC:0001415889-24-011233:0
2,323 shares@ US$66.5319.5% of flowCommon StockSEC:0001415889-24-010000:0
4,099 shares0Common StockSEC:0001415889-24-008520:0
20,000 shares0Common StockSEC:0001415889-24-006476:0
3,695 sharesCommon StockSEC:0000950170-24-017412:0
25 of 45 declarations
About Wassil Jim
Jim Wassil is the Chief Operating Officer of Vaxcyte, Inc. and Icosavax, Inc. He oversees the operations of both companies, ensuring efficiency and strategic alignment. His experience in the biopharmaceutical sector is an asset to both organizations.
